跳至主要内容
临床试验/NCT05677724
NCT05677724招募中不适用

Single-cell RNA Sequencing Resolves the Regulatory Role of HBV on the Hepatocellular Carcinoma Immune Microenvironment

Fubing Wang1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20
试验地点
1
主要终点
single cell RNA sequencing

研究概览

简要总结

In summary, with the help of single-cell sequencing technology, this study aims to focus on elucidating the influence of HBV-induced hepatocellular carcinoma cell metabolic changes on microenvironment remodeling. With the help of hepatocellular carcinoma microenvironment changes, this study provide a more accurate diagnosis and treatment method for HBV-induced hepatocellular carcinoma.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with primary liver cancer (hepatocellular carcinoma (HCC)), with evidence of histological or cytological diagnosis, or with HCC meeting conventional clinical diagnostic criteria.
  • Both sexes, aged 18-80 years old
  • The results of HBVDNA test were in line with the inclusion criteria
  • The patient had at least one measurable lesion according to the Response Evaluation Criteria in Solid Tumors, version 1.1 (RECIST V1.1)
  • Agreed to comply with the study protocol for treatment and follow-up, agreed to provide clinicopathological and follow-up data required by the study, and agreed to use the study data for subsequent research and product development

排除标准

  • Other malignant tumors;
  • Patients with severe organic diseases do not meet the requirements of infectious liver cancer in this study;
  • Suffering from mental illness cannot guarantee the compliance of this study;
  • Previous recipients of any cell or organ transplantation;
  • Received local regional liver therapy (including various ablations, percutaneous ethanol or acetic acid injections, high-intensity focused ultrasound, transarterial embolization, chemotherapy, or chemoembolization plus embolization) within 14 days prior to study treatment initiation.

结局指标

主要结局

single cell RNA sequencing

时间窗: within 4 hours after the sample was submitted for examination

10x genomics chromium 3' sequencing

Biochemical index detection

时间窗: within 4 hours after the sample was submitted for examination

HbsAg (IU/mL) \\HbsAb (mIU/mL)\\HbeAg\\HbeAb\\HbcAb

HBV DNA copy number

时间窗: within 24 hours after the sample was submitted for examination

HBV DNA (IU/mL)

次要结局

未报告次要终点

研究者

发起方
Fubing Wang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Fubing Wang

Dr.Prof.

Zhongnan Hospital

研究点 (1)

Loading locations...

相似试验

Single-cell RNA Sequencing Resolves the Regulatory... | 临床试验